1. Home
  2. ZLAB vs VIST Comparison

ZLAB vs VIST Comparison

Compare ZLAB & VIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • VIST
  • Stock Information
  • Founded
  • ZLAB 2013
  • VIST 2017
  • Country
  • ZLAB China
  • VIST Mexico
  • Employees
  • ZLAB N/A
  • VIST N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • VIST Oil & Gas Production
  • Sector
  • ZLAB Health Care
  • VIST Energy
  • Exchange
  • ZLAB Nasdaq
  • VIST Nasdaq
  • Market Cap
  • ZLAB 4.3B
  • VIST 5.1B
  • IPO Year
  • ZLAB 2017
  • VIST 2019
  • Fundamental
  • Price
  • ZLAB $34.96
  • VIST $42.43
  • Analyst Decision
  • ZLAB Buy
  • VIST Strong Buy
  • Analyst Count
  • ZLAB 5
  • VIST 4
  • Target Price
  • ZLAB $54.28
  • VIST $65.75
  • AVG Volume (30 Days)
  • ZLAB 860.8K
  • VIST 1.1M
  • Earning Date
  • ZLAB 08-07-2025
  • VIST 07-10-2025
  • Dividend Yield
  • ZLAB N/A
  • VIST N/A
  • EPS Growth
  • ZLAB N/A
  • VIST 26.19
  • EPS
  • ZLAB N/A
  • VIST 5.47
  • Revenue
  • ZLAB $427,799,000.00
  • VIST $1,982,699,000.00
  • Revenue This Year
  • ZLAB $45.16
  • VIST $38.98
  • Revenue Next Year
  • ZLAB $56.81
  • VIST $18.03
  • P/E Ratio
  • ZLAB N/A
  • VIST $8.16
  • Revenue Growth
  • ZLAB 32.56
  • VIST 49.52
  • 52 Week Low
  • ZLAB $16.01
  • VIST $32.11
  • 52 Week High
  • ZLAB $44.34
  • VIST $61.67
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 45.24
  • VIST 39.40
  • Support Level
  • ZLAB $33.17
  • VIST $42.04
  • Resistance Level
  • ZLAB $39.64
  • VIST $46.70
  • Average True Range (ATR)
  • ZLAB 1.19
  • VIST 1.83
  • MACD
  • ZLAB -0.31
  • VIST 0.08
  • Stochastic Oscillator
  • ZLAB 22.29
  • VIST 14.57

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value

Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.

Share on Social Networks: